Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals Cover

.blurhash-client-img { display: none !important; }

Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals

Radiology and Oncology

Volume 52 (2018): Issue 3 (September 2018)

By: Borut Kobal, Marco Noventa, Branko Cvjeticanin, Matija Barbic, Leon Meglic, Marusa Herzog, Giulia Bordi, Amerigo Vitagliano, Carlo Saccardi and Erik Skof

Open Access

|Sep 2018

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/raon-2018-0030 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 307 - 319

Submitted on: Mar 28, 2018

|

Accepted on: Jul 23, 2018

|

Published on: Sep 11, 2018

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

epithelial ovarian cancer,

advanced stage,

primary debulking surgery,

interval debulking surgery,

neoadjuvant chemotherapy,

adjuvant chemotherapy,

overall survival,

progression free survival

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2018 Borut Kobal, Marco Noventa, Branko Cvjeticanin, Matija Barbic, Leon Meglic, Marusa Herzog, Giulia Bordi, Amerigo Vitagliano, Carlo Saccardi, Erik Skof, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 52 (2018): Issue 3 (September 2018)Next article